XT
MIRA icon

XTX Topco’s MIRA Pharmaceuticals MIRA Stock Holding History

XTX Topco’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40.2K Buy
37,573
+16,669
+80% +$20.9K ﹤0.01% 3378
2025
Q4 		$31.6K Sell
20,904
-15,019
-42% -$22.1K ﹤0.01% 2952
2025
Q3 		$48.9K Buy
35,923
+14,050
+64% +$20.4K ﹤0.01% 2176
2025
Q2 		$26.5K Buy
+21,873
New +$25.3K ﹤0.01% 2126
2024
Q2 		– Sell
-25,544
Closed -$28.1K – 2235
2024
Q1 		$28.1K Buy
+25,544
New +$27.7K ﹤0.01% 1563

Other funds holding MIRA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

XTX Topco's MIRA Position: Q1 2026 in Review

XTX Topco increased its MIRA Pharmaceuticals (MIRA) stake by 80% in Q1 2026, buying an estimated $20.9K and bringing the position to 37,573 shares worth $40.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3378.

XTX Topco first reported a position in MIRA in Q1 2024 and has held it in 5 quarters since. The position peaked at $48.9K in Q3 2025. 26 funds tracked by Wall St. Rank hold MIRA as of Q1 2026.

  • XTX Topco held 37,573 shares of MIRA Pharmaceuticals worth $40.2K as of Q1 2026.
  • XTX Topco bought 16,669 MIRA Pharmaceuticals shares in Q1 2026, an estimated $20.9K.
  • MIRA Pharmaceuticals made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3378 holding.
  • XTX Topco first reported a position in MIRA Pharmaceuticals in Q1 2024 and has held it in 5 quarters since.
  • XTX Topco's MIRA Pharmaceuticals position peaked at $48.9K in Q3 2025.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.